550 related articles for article (PubMed ID: 29335749)
1. Diversity among POU transcription factors in chromatin recognition and cell fate reprogramming.
Malik V; Zimmer D; Jauch R
Cell Mol Life Sci; 2018 May; 75(9):1587-1612. PubMed ID: 29335749
[TBL] [Abstract][Full Text] [Related]
2. Changing POU dimerization preferences converts Oct6 into a pluripotency inducer.
Jerabek S; Ng CK; Wu G; Arauzo-Bravo MJ; Kim KP; Esch D; Malik V; Chen Y; Velychko S; MacCarthy CM; Yang X; Cojocaru V; Schöler HR; Jauch R
EMBO Rep; 2017 Feb; 18(2):319-333. PubMed ID: 28007765
[TBL] [Abstract][Full Text] [Related]
3. Selective influence of Sox2 on POU transcription factor binding in embryonic and neural stem cells.
Mistri TK; Devasia AG; Chu LT; Ng WP; Halbritter F; Colby D; Martynoga B; Tomlinson SR; Chambers I; Robson P; Wohland T
EMBO Rep; 2015 Sep; 16(9):1177-91. PubMed ID: 26265007
[TBL] [Abstract][Full Text] [Related]
4. Cooperative Binding of Transcription Factors Orchestrates Reprogramming.
Chronis C; Fiziev P; Papp B; Butz S; Bonora G; Sabri S; Ernst J; Plath K
Cell; 2017 Jan; 168(3):442-459.e20. PubMed ID: 28111071
[TBL] [Abstract][Full Text] [Related]
5. Pioneer transcription factors in cell reprogramming.
Iwafuchi-Doi M; Zaret KS
Genes Dev; 2014 Dec; 28(24):2679-92. PubMed ID: 25512556
[TBL] [Abstract][Full Text] [Related]
6. Quantitative profiling of selective Sox/POU pairing on hundreds of sequences in parallel by Coop-seq.
Chang YK; Srivastava Y; Hu C; Joyce A; Yang X; Zuo Z; Havranek JJ; Stormo GD; Jauch R
Nucleic Acids Res; 2017 Jan; 45(2):832-845. PubMed ID: 27915232
[TBL] [Abstract][Full Text] [Related]
7.
Bhagirath D; Yang TL; Tabatabai ZL; Majid S; Dahiya R; Tanaka Y; Saini S
Clin Cancer Res; 2019 Nov; 25(21):6532-6545. PubMed ID: 31371344
[TBL] [Abstract][Full Text] [Related]
8. Cell fate reprogramming through engineering of native transcription factors.
Jauch R
Curr Opin Genet Dev; 2018 Oct; 52():109-116. PubMed ID: 29980007
[TBL] [Abstract][Full Text] [Related]
9. Fine-tuning of intrinsic N-Oct-3 POU domain allostery by regulatory DNA targets.
Alazard R; Mourey L; Ebel C; Konarev PV; Petoukhov MV; Svergun DI; Erard M
Nucleic Acids Res; 2007; 35(13):4420-32. PubMed ID: 17576670
[TBL] [Abstract][Full Text] [Related]
10. Pioneer transcription factors target partial DNA motifs on nucleosomes to initiate reprogramming.
Soufi A; Garcia MF; Jaroszewicz A; Osman N; Pellegrini M; Zaret KS
Cell; 2015 Apr; 161(3):555-568. PubMed ID: 25892221
[TBL] [Abstract][Full Text] [Related]
11. The virtuoso of versatility: POU proteins that flex to fit.
Phillips K; Luisi B
J Mol Biol; 2000 Oct; 302(5):1023-39. PubMed ID: 11183772
[TBL] [Abstract][Full Text] [Related]
12. Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming.
Jin W; Wang L; Zhu F; Tan W; Lin W; Chen D; Sun Q; Xia Z
Sci Rep; 2016 Feb; 6():20818. PubMed ID: 26877091
[TBL] [Abstract][Full Text] [Related]
13. Transient and Permanent Reconfiguration of Chromatin and Transcription Factor Occupancy Drive Reprogramming.
Knaupp AS; Buckberry S; Pflueger J; Lim SM; Ford E; Larcombe MR; Rossello FJ; de Mendoza A; Alaei S; Firas J; Holmes ML; Nair SS; Clark SJ; Nefzger CM; Lister R; Polo JM
Cell Stem Cell; 2017 Dec; 21(6):834-845.e6. PubMed ID: 29220667
[TBL] [Abstract][Full Text] [Related]
14. OCT4: dynamic DNA binding pioneers stem cell pluripotency.
Jerabek S; Merino F; Schöler HR; Cojocaru V
Biochim Biophys Acta; 2014 Mar; 1839(3):138-54. PubMed ID: 24145198
[TBL] [Abstract][Full Text] [Related]
15. Pioneer transcription factors, chromatin dynamics, and cell fate control.
Zaret KS; Mango SE
Curr Opin Genet Dev; 2016 Apr; 37():76-81. PubMed ID: 26826681
[TBL] [Abstract][Full Text] [Related]
16. Hierarchical mechanisms for direct reprogramming of fibroblasts to neurons.
Wapinski OL; Vierbuchen T; Qu K; Lee QY; Chanda S; Fuentes DR; Giresi PG; Ng YH; Marro S; Neff NF; Drechsel D; Martynoga B; Castro DS; Webb AE; Südhof TC; Brunet A; Guillemot F; Chang HY; Wernig M
Cell; 2013 Oct; 155(3):621-35. PubMed ID: 24243019
[TBL] [Abstract][Full Text] [Related]
17. The homeodomain of Oct4 is a dimeric binder of methylated CpG elements.
Tan DS; Cheung SL; Gao Y; Weinbuch M; Hu H; Shi L; Ti SC; Hutchins AP; Cojocaru V; Jauch R
Nucleic Acids Res; 2023 Feb; 51(3):1120-1138. PubMed ID: 36631980
[TBL] [Abstract][Full Text] [Related]
18. Directed Evolution of an Enhanced POU Reprogramming Factor for Cell Fate Engineering.
Tan DS; Chen Y; Gao Y; Bednarz A; Wei Y; Malik V; Ho DH; Weng M; Ho SY; Srivastava Y; Velychko S; Yang X; Fan L; Kim J; Graumann J; Stormo GD; Braun T; Yan J; Schöler HR; Jauch R
Mol Biol Evol; 2021 Jun; 38(7):2854-2868. PubMed ID: 33720298
[TBL] [Abstract][Full Text] [Related]
19. Protein interaction surface of the POU transcription factor UNC-86 selectively used in touch neurons.
Röhrig S; Röckelein I; Donhauser R; Baumeister R
EMBO J; 2000 Jul; 19(14):3694-703. PubMed ID: 10899123
[TBL] [Abstract][Full Text] [Related]
20. A core paired-type and POU homeodomain-containing transcription factor program drives retinal bipolar cell gene expression.
Kim DS; Matsuda T; Cepko CL
J Neurosci; 2008 Jul; 28(31):7748-64. PubMed ID: 18667607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
